![Protease inhibitors / Fixed dose combination / Gilead Sciences / Bristol-Myers Squibb / Darunavir / Antiretroviral drug / Emtricitabine/tenofovir/efavirenz / Tenofovir/emtricitabine / Raltegravir / Chemistry / Organic chemistry / Organofluorides Protease inhibitors / Fixed dose combination / Gilead Sciences / Bristol-Myers Squibb / Darunavir / Antiretroviral drug / Emtricitabine/tenofovir/efavirenz / Tenofovir/emtricitabine / Raltegravir / Chemistry / Organic chemistry / Organofluorides](https://www.pdfsearch.io/img/c89bfdb74d5d706ea6b3b4d59ce0f548.jpg) Date: 2014-05-15 13:36:00Protease inhibitors Fixed dose combination Gilead Sciences Bristol-Myers Squibb Darunavir Antiretroviral drug Emtricitabine/tenofovir/efavirenz Tenofovir/emtricitabine Raltegravir Chemistry Organic chemistry Organofluorides | | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets for oAdd to Reading ListSource URL: www.accessdata.fda.govDownload Document from Source Website File Size: 919,42 KBShare Document on Facebook
|